Search
for
Sort by
Research 30 of 549
- Depressive Symptoms and Suicidal Thoughts Among Former Users of Finasteride With Persistent Sexual Side Effects
- Depressive Symptoms and Suicidal Thoughts Among Former Users of Finasteride With Persistent Sexual Side Effects
- Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts
- Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects
- Depression, suicidal thoughts with finasteride (Propecia)
- Finasteride and Suicide: A Postmarketing Case Series
- Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia
- Finasteride-Induced Neuropsychiatric Reactions
- How does the hair-loss drug finasteride work? Can it affect my mental health?
- Finasteride: risk of suicidality and depression
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- Finasteride drug safety alert
- Assessing the quality of life and health outcomes of Androgenic Alopecia patients using Propecia
- Finasteride- and dutasteride-related suicidal ideation
- Finasteride linked with suicidal ideation/self-harm
- Systematic review: depression, suicidal ideation with finasteride
- No clear link between finasteride and suicidality
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sunscreen: Cosmetic or medical therapy?
- Post-finasteride syndrome: pharmacists must lead the conversation on patient safety
- Sun protection policies and behaviors among U.S. child care centers
- Re: Association of Suicidality and Depression with 5α-Reductase Inhibitors
- Safety update: psychiatric and sexual adverse effects with finasteride
- Young patients using finasteride exhibit risk of suicidality
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Depression common with sexual dysfunction after finasteride
- Med Check
- Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Psychosocial Aspects of Hair Loss